ATE121459T1 - Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t. - Google Patents

Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t.

Info

Publication number
ATE121459T1
ATE121459T1 AT91103055T AT91103055T ATE121459T1 AT E121459 T1 ATE121459 T1 AT E121459T1 AT 91103055 T AT91103055 T AT 91103055T AT 91103055 T AT91103055 T AT 91103055T AT E121459 T1 ATE121459 T1 AT E121459T1
Authority
AT
Austria
Prior art keywords
factors
antibiotics
antibiotic
medicaments
directed
Prior art date
Application number
AT91103055T
Other languages
English (en)
Inventor
Enrico Selva
Paolo Tavecchia
Ermenegildo Restelli
Pietro Ferrari
Maurizio Denaro
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE121459T1 publication Critical patent/ATE121459T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91103055T 1990-03-08 1991-03-01 Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t. ATE121459T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90104409 1990-03-08
EP90120214 1990-10-22

Publications (1)

Publication Number Publication Date
ATE121459T1 true ATE121459T1 (de) 1995-05-15

Family

ID=26125004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91103055T ATE121459T1 (de) 1990-03-08 1991-03-01 Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t.

Country Status (11)

Country Link
US (2) US5747295A (de)
EP (1) EP0451486B1 (de)
JP (1) JP3107584B2 (de)
KR (1) KR0165684B1 (de)
AT (1) ATE121459T1 (de)
CA (1) CA2037779C (de)
DE (1) DE69108972T2 (de)
DK (1) DK0451486T3 (de)
ES (1) ES2071143T3 (de)
GR (1) GR3015899T3 (de)
IE (1) IE67973B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0529410B1 (de) * 1991-08-30 1998-02-25 Biosearch Italia S.p.A. Faktor C2a des Antibiotikums CE 2270
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
EP0791069A1 (de) * 1994-11-08 1997-08-27 Biosearch Italia S.p.A. Verfahren zur herstellung von antibiotikum ge 2270 faktor d 2 mittels eines mikrobiellen umwandlungsverfahrens
SI0801655T1 (en) * 1995-02-07 1998-08-31 Biosearch Italia S.P.A. Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
JP3518606B2 (ja) * 1995-02-07 2004-04-12 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ Ｇｅ２２７０及びｇｅ２２７０−様抗生物質の塩基性オキサゾリン−アミド誘導体
JP2000505438A (ja) * 1996-02-14 2000-05-09 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ＧＥ２２７０因子Ｃ▲下２ａ▼、Ｄ▲下２▼およびＥの誘導体
DE102004031656A1 (de) * 2004-06-30 2006-01-19 Merck Patent Gmbh Tetrahydrochinoline
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
EA200900816A1 (ru) * 2006-12-20 2009-12-30 Новартис Аг Антибактериальные соединения и способы их получения
AU2008258639B2 (en) * 2007-06-04 2012-07-05 Novartis Ag Macrocycles and their uses
PE20091108A1 (es) 2007-12-12 2009-08-24 Novartis Ag Aminotiazoles y sus usos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2399247A1 (fr) * 1977-08-04 1979-03-02 Rhone Poulenc Ind Antibiotique 35665 rp, sa preparation et les compositions qui les contiennent
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
EP0406745B1 (de) * 1989-07-04 1995-01-25 GRUPPO LEPETIT S.p.A. Antibiotikum GE 22270, Faktoren A1,A2,A3 und H
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
EP0529410B1 (de) * 1991-08-30 1998-02-25 Biosearch Italia S.p.A. Faktor C2a des Antibiotikums CE 2270
JP2000505438A (ja) * 1996-02-14 2000-05-09 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ＧＥ２２７０因子Ｃ▲下２ａ▼、Ｄ▲下２▼およびＥの誘導体

Also Published As

Publication number Publication date
IE910754A1 (en) 1991-09-11
IE67973B1 (en) 1996-05-15
DK0451486T3 (da) 1995-05-08
CA2037779C (en) 2002-11-05
DE69108972T2 (de) 1995-10-19
DE69108972D1 (de) 1995-05-24
ES2071143T3 (es) 1995-06-16
US5843890A (en) 1998-12-01
EP0451486A1 (de) 1991-10-16
EP0451486B1 (de) 1995-04-19
JP3107584B2 (ja) 2000-11-13
KR910016938A (ko) 1991-11-05
KR0165684B1 (ko) 1999-01-15
CA2037779A1 (en) 1991-09-09
GR3015899T3 (en) 1995-07-31
JPH04217988A (ja) 1992-08-07
US5747295A (en) 1998-05-05

Similar Documents

Publication Publication Date Title
BR1100089A (pt) Novas sulfonilaminopirimidinas, sua preparação e emprego como medicamento
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
ATE121459T1 (de) Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t.
DE3682767D1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone.
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
ATE117724T1 (de) Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
DE3780644D1 (de) Glykopeptid-antibiotika.
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
DE68926972D1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
ES2113391T3 (es) Factor c2a de antibiotico ge 2270.
BR9306207A (pt) Composiçao farmacéutica e processo para o tratamento de infecçao ou doença causada pelo vírus da hepatite b processo para a preparaçao da composiçao e uso de fiau ou de uma pró-droga ou metabolito do mesmo
DE69216746D1 (de) Propanolamin-Cyclohexapeptide
DE69317058D1 (de) Die antibiotika ge 37468 a, b und c
EP0359062A3 (de) Antibiotikum GE 2270
DE69004941D1 (de) Arzneimittelformulierungen zum Erhöhen der Wirksamkeit von Betalaktamantibiotika in Prophylaxe und Behandlung von infektiöser Krankheit infolge pathogener Bakterien.
IL91427A0 (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee